CNTX
Price
$2.00
Change
+$0.20 (+11.11%)
Updated
May 17, 6:59 PM EST
82 days until earnings call
FATE
Price
$3.90
Change
-$0.25 (-6.02%)
Updated
May 17, 6:59 PM EST
74 days until earnings call
Ad is loading...

CNTX vs FATE

Header iconCNTX vs FATE Comparison
Open Charts CNTX vs FATEBanner chart's image
Context Therapeutics
Price$2.00
Change+$0.20 (+11.11%)
Volume$393.8K
CapitalizationN/A
Fate Therapeutics
Price$3.90
Change-$0.25 (-6.02%)
Volume$929.12K
CapitalizationN/A
View a ticker or compare two or three
CNTX vs FATE Comparison Chart

Loading...

CNTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
FATEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CNTX vs. FATE commentary
May 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTX is a StrongBuy and FATE is a Hold.

COMPARISON
Comparison
May 18, 2024
Stock price -- (CNTX: $2.00 vs. FATE: $4.14)
Brand notoriety: CNTX and FATE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTX: 85% vs. FATE: 59%
Market capitalization -- CNTX: $150M vs. FATE: $443.94M
CNTX [@Biotechnology] is valued at $150M. FATE’s [@Biotechnology] market capitalization is $443.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $593.52B to $0. The average market capitalization across the [@Biotechnology] industry is $2.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTX’s FA Score shows that 0 FA rating(s) are green whileFATE’s FA Score has 0 green FA rating(s).

  • CNTX’s FA Score: 0 green, 5 red.
  • FATE’s FA Score: 0 green, 5 red.
According to our system of comparison, FATE is a better buy in the long-term than CNTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTX’s TA Score shows that 4 TA indicator(s) are bullish while FATE’s TA Score has 4 bullish TA indicator(s).

  • CNTX’s TA Score: 4 bullish, 4 bearish.
  • FATE’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, FATE is a better buy in the short-term than CNTX.

Price Growth

CNTX (@Biotechnology) experienced а +6.95% price change this week, while FATE (@Biotechnology) price change was +6.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.41%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was +60.72%.

Reported Earning Dates

CNTX is expected to report earnings on Aug 08, 2024.

FATE is expected to report earnings on Jul 31, 2024.

Industries' Descriptions

@Biotechnology (+1.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CNTX with price predictions.
OPEN
A.I.dvisor published
a Summary for FATE with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
FATE($444M) has a higher market cap than CNTX($150M). CNTX YTD gains are higher at: 76.991 vs. FATE (10.695).
CNTXFATECNTX / FATE
Capitalization150M444M34%
EBITDAN/AN/A-
Gain YTD76.99110.695720%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CNTXFATE
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
CNTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
FATEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TSLIX6.050.03
+0.50%
Transamerica Small Cap Value I
PMDAX18.540.05
+0.27%
Principal Small-MidCap Dividend Inc A
DVLCX24.72N/A
N/A
BNY Mellon Opportunistic Midcap Value C
PGSVX11.98N/A
N/A
Pioneer Global Sustainable Value A
VSMSX407.32-0.57
-0.14%
Vanguard S&P Small-Cap 600 Index I